ALFONSO
GOMEZ DE ITURRIAGA PIÑA
PROFESORADO AGREGADO
Publicaciones (69) Publicaciones de ALFONSO GOMEZ DE ITURRIAGA PIÑA
2024
-
Criteria and indicators to evaluate quality of care in genitourinary tumour boards
Clinical and Translational Oncology
-
Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities
Clinical and Translational Radiation Oncology, Vol. 45
-
Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach
Radiotherapy and Oncology, Vol. 190
2023
-
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer
Actas Urologicas Espanolas, Vol. 47, Núm. 2, pp. 111-126
-
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply
Actas Urologicas Espanolas
-
ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy
Clinical and Translational Radiation Oncology, Vol. 43
-
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer
Clinical and Translational Radiation Oncology, Vol. 41
-
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer
World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838
-
Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer
Radiotherapy and Oncology, Vol. 186
2022
-
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial
Radiotherapy and Oncology, Vol. 172, pp. 1-9
-
Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
Frontiers in Oncology, Vol. 12
-
Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy
Reports of Practical Oncology and Radiotherapy, Vol. 27, Núm. 3, pp. 428-439
-
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
Radiotherapy and Oncology, Vol. 176, pp. 199-207
-
Should brachytherapy be added to external beam radiotherapy for prostate cancer?
The Lancet Oncology, Vol. 23, Núm. 1, pp. 23-25
2021
-
A retrospective study on the potential of 99mTc-HDP imaging before therapy for individualizing treatments with 223Ra-Cl2 for metastatic castration resistant prostate cancer
Medical Physics, Vol. 48, Núm. 3, pp. 1395-1403
-
Adjuvant versus early salvage radiotherapy for prostate cancer patients: Time to move on
Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 6, pp. 351-356
-
Extreme hypofractionation with sbrt in localized prostate cancer
Current Oncology, Vol. 28, Núm. 4, pp. 2933-2949
-
Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: Toxicity, prostatespecific antigen kinetics, and cancer control
Journal of Contemporary Brachytherapy, Vol. 13, Núm. 1, pp. 12-17
-
Salvage local treatment for localized radio-recurrent prostate cancer: A narrative review and future perspectives
Future Oncology, Vol. 17, Núm. 31, pp. 4207-4219
-
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases
European Urology Focus